Correction

Generation of a set of isogenic, gene-edited iPSC lines homozygous for all main APOE variants and an APOE knock-out line (vol 34, 101349, 2019)

STEM CELL RESEARCH (2020)

Journal

STEM CELL RESEARCH

Volume 48, Issue -, Pages -

Publisher

ELSEVIER

DOI: 10.1016/j.scr.2020.102005

Keywords

-

Categories

Cell & Tissue Engineering Biotechnology & Applied Microbiology Cell Biology

Funding

Innovative Medicines Initiative 2 Joint Undertaking [115975]
European Union's Horizon 2020 research and innovation programme
European Federation of Pharmaceutical Industries and Associations

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Recommended

Article Cell & Tissue Engineering

Generation of a set of isogenic iPSC lines carrying all APOE genetic variants (ε2/ε3/ε4) and knock-out for the study of APOE biology in health and disease

Benjamin Schmid, Bjorn Holst, Christian Clausen, Lamiaa Bahnassawy, Peter Reinhardt, Margot H. M. Bakker, Eva Diaz-Guerra, Carlos Vicario, Pamela Martino-Adami, Michaela Thoenes, Alfredo Ramirez, Klaus Flissbach, Clara Grezella, Oliver Bruestle, Michael Peitz, Andreas Ebneth, Alfredo Cabrera-Socorro

Summary: The APOE genotype is the strongest genetic risk factor for AD, and the low homology between mouse and human APOE is a concerning issue in current preclinical models. The ADAPTED project aims to generate in vitro models that better reflect human APOE biology.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM)

Anna Janz, Miriam Zink, Alexandra Cirnu, Annika Hartleb, Christina Albrecht, Simone Rost, Eva Klopocki, Katharina Guenther, Frank Edenhofer, Sueleyman Erguen, Brenda Gerull

Summary: The researchers successfully generated gene-edited knock-out iPSC lines for PKP2 and DSG2 using the CRISPR/Cas9 system in a healthy control iPSC background, providing a novel isogenic human in vitro model system for studying arrhythmogenic cardiomyopathy.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population

B. Kuebler, B. Alvarez-Palomo, B. Aran, J. Castano, L. Rodriguez, A. Raya, S. Querol Giner, A. Veiga

Summary: This study established the first clinical-grade iPSC haplobank in Spain, utilizing allogenic HLA-matched donors to generate iPSC lines. The iPSCs were expanded and stored under GMP conditions. These iPSCs will be used for the development of advanced therapy medicinal products.

STEM CELL RESEARCH & THERAPY (2023)

Add to Collection

Article Cell & Tissue Engineering

Generation of heterozygous (MRli003-A-3) and homozygous (MRli003-A-4) TRPM4 knockout human iPSC lines

Fangfang Zhang, Anna B. B. Meier, Peter Lipp, Karl-Ludwig Laugwitz, Tatjana Dorn, Alessandra Moretti

Summary: Using CRISPR/Cas9 gene editing technology, researchers successfully established TRPM4 knockout human induced pluripotent stem cell lines, which can further contribute to the study of the relationship between this gene and cardiac arrhythmias.

STEM CELL RESEARCH (2022)

Add to Collection

Article Cell & Tissue Engineering

Generation of two iPSC lines from long QT syndrome patients carrying SNTA1 variants

Nerea Jimenez-Tellez, Carlos D. Vera, Zehra Yildirim, Julio Vicente Guevara, Tina Zhang, Joseph C. Wu

Summary: Long QT syndrome (LQTS) is a genetic cardiovascular disorder characterized by electrical conduction abnormalities, leading to arrhythmia, fainting, seizures, and an increased risk of sudden death. Researchers generated two human-induced pluripotent stem cell (iPSC) lines from LQT patients carrying a mutation in SNTA1 gene. These iPSC lines showed normal properties and pluripotency markers, making them valuable for studying the pathological mechanisms of LQTS related to the SNTA1 variant.

STEM CELL RESEARCH (2023)

Add to Collection

Article Cell & Tissue Engineering

Generation of homozygous Nav1.8 knock-out iPSC lines by CRISPR Cas9 genome editing to investigate a potential new antiarrhythmic strategy

Wiebke Maurer, Nico Hartmann, Loukas Argyriou, Samuel Sossalla, Katrin Streckfuss-Boemeke

Summary: In this study, induced pluripotent stem cells (iPSCs) with a homozygous SCN10A knockout were generated using CRISPR Cas9 genome editing. The edited iPSCs retained their pluripotency and differentiation capacity, allowing for the investigation of the role of Na(v)1.8 in the heart.

STEM CELL RESEARCH (2022)

Add to Collection

Article Cell & Tissue Engineering

Generation of two heterozygous GATA2 CRISPR/Cas9-edited iPSC lines, R398W and R396Q, for modeling GATA2 deficiency

Julio Castano, Damia Romero-Moya, Yvonne Richaud-Patin, Alessandra Giorgetti

Summary: The study successfully generated high-quality human induced pluripotent stem cell lines carrying two common GATA2 gene mutations using CRISPR/Cas9, providing an in vitro model for studying the molecular and cellular mechanisms underlying GATA2 deficiency.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants

Amit Manhas, James W. S. Jahng, Carlos D. Vera, Sushma P. Shenoy, Joshua W. Knowles, Joseph C. Wu

Summary: In this study, two induced pluripotent stem cell lines were generated from HCM patients carrying mutations in MYBPC3 and PRKAG2, providing valuable tools for investigating the pathological mechanisms of HCM.

STEM CELL RESEARCH (2022)

Add to Collection

Article Cell & Tissue Engineering

Generation and characterization of two iPSC lines carrying heterozygous or homozygous nonsense mutation in PROM1 gene from a single family

Ping Xu, Fuying Guo, Bingbing Xie, Xiufeng Zhong

Summary: PROM1-related retinal dystrophy is a hereditary retinal disorder that causes progressive damage to the photoreceptors. By studying induced pluripotent stem cell lines from a patient with PROM1-related retinal dystrophy and his healthy mother, we can gain insights into the disease mechanisms and potentially develop treatments.

STEM CELL RESEARCH (2022)

Add to Collection

Article Cell & Tissue Engineering

Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression

Eric Schoger, Wolfram-Hubertus Zimmermann, Lukas Cyganek, Laura Cecilia Zelarayan

Summary: Using nuclease-deficient dCas9 fused to transcriptional inhibitors allows for transcriptional interference and has been successfully applied in hiPSC lines for studying endogenous transcriptional repression. The hiPSC-CRISPRi cell lines offer a valuable tool for studying human cell types with single and multiplexed possibilities.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

Generation of heterozygous (MRli003-A-5) and homozygous (MRli003-A-6) voltage-sensing knock-in human iPSC lines by CRISPR/Cas9 editing of the AAVS1 locus

Fangfang Zhang, Anna B. Meier, Daniel Sinnecker, Stefan Engelhardt, Peter Lipp, Karl-Ludwig Laugwitz, Tatjana Dorn, Alessandra Moretti

Summary: Assessment of cardiomyocyte electrophysiological properties is crucial for understanding cardiac disorders and drug screening. Optical action potential imaging using a genetically encoded voltage-sensing fluorescent protein (VSFP) provides a high-throughput method for functional characterization of cardiomyocytes. This study successfully integrated VSFP into human induced pluripotent stem cells, creating two stable voltage indicator lines, which can be used for optical membrane potential recordings and have wide applications in cardiovascular biomedicine.

STEM CELL RESEARCH (2022)

Add to Collection

Article Cell & Tissue Engineering

Generation of two gene corrected human isogenic iPSC lines (NCATS-CL6104 and NCATS-CL6105) from a patient line (NCATS-CL6103) carrying a homozygous p.R401X mutation in the NGLY1 gene using CRISPR/Cas9

Ivan Pavlinov, Atena Farkhondeh, Shu Yang, Miao Xu, Yu-Shan Cheng, Jeanette Beers, Jizhong Zou, Chengyu Liu, Matthew Might, Steven Rodems, Karsten Baumgartel, Wei Zheng

Summary: Two gene-corrected iPSC lines were generated using a patient-derived iPSC line with a homozygous p.R401X mutation in the NGLY1 gene, serving as control for a cell-based NGLY1 disease model and aiding in the study of disease pathophysiology and evaluation of therapeutics in development.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

Generation of two iPSC lines from siblings of a homozygous patient with hearing loss and a heterozygous carrier with normal hearing carrying p.G45E/Y136X mutation in GJB2

Ichiro Fukunaga, Yoko Oe, Keiko Danzaki, Sayaka Ohta, Cheng Chen, Madoka Iizumi, Takahiro Shiga, Rina Matsuoka, Takashi Anzai, Remi Hibiya-Motegi, Shori Tajima, Katsuhisa Ikeda, Wado Akamatsu, Kazusaku Kamiya

Summary: In this study, two iPSC lines carrying G45E/Y136X mutation in GJB2 gene were generated from siblings with moderate-to-severe hearing loss and normal hearing, respectively. These iPSC lines expressed pluripotency markers and could differentiate into three germ layers, making them a powerful tool for investigating the pathogenesis of GJB2-related deafness.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

Induced pluripotent stem cell (iPSC) lines from two individuals carrying a homozygous (BGUi007-A) and a heterozygous (BGUi006-A) mutation in ELP1 for in vitro modeling of familial dysautonomia

Lior Dor, Tatiana Rabinski, Dor Zlotnik, Michal Shilian, Miguel Weil, Gad D. Vatine

Summary: This study reported the generation of induced pluripotent stem cell lines from an FD patient and his family member, retaining the disease-causing mutation and demonstrating pluripotency markers. These cell lines can differentiate into three germ layers, indicating their potential usefulness for studying FD.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

Establishment of iPSC line from a Chinese infant (XACHi012-A) with Jervell and Lange-Nielsen syndrome carrying combined KCNQ1 frameshift c.431delC(p.I145Sfs*92) and nonsense c.1175G > A (p.W392X) variants and two iPSC lines from the parents (XACHi013-A, XACHi014-A)

Yafei Zhou, Jie Wang, Huan Li, Anmao Li, Guoxia Wang, Xiaoqiu Tan, Ming Lei, Yanmin Zhang

Summary: Induced pluripotent stem cell lines (iPSCs) were generated from peripheral blood mononuclear cells (PBMCs) isolated from a two month-old boy and his parents. The iPSCs expressed pluripotent markers, exhibited trilineage differentiation potential, carried identified KCNQ1 variants, and had a normal karyotype, making them useful tools for studying the pathophysiological mechanism of JLNS and drug testing.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

Development and implementation of large-scale quality control for the European bank for induced Pluripotent Stem Cells

Orla O'Shea, Rachel Steeg, Charlotte Chapman, Peter Mackintosh, Glyn N. Stacey

STEM CELL RESEARCH (2020)

Add to Collection

Article Multidisciplinary Sciences

CDH6 and HAGH protein levels in plasma associate with Alzheimer's disease in APOE ε4 carriers

Shahzad Ahmad, Marta del Campo Milan, Oskar Hansson, Ayse Demirkan, Ruiz Agustin, Maria E. Saez, Nikolaos Giagtzoglou, Alfredo Cabrera-Socorro, Margot H. M. Bakker, Alfredo Ramirez, Thomas Hankemeier, Erik Stomrud, Niklas Mattsson-Carlgren, Philip Scheltens, Wiesje M. van der Flier, M. Arfan Ikram, Anders Malarstig, Charlotte E. Teunissen, Najaf Amin, Cornelia M. van Duijn

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Cell & Tissue Engineering

Access to stem cell data and registration of pluripotent cell lines: The Human Pluripotent Stem Cell Registry (hPSCreg)

Nancy Mah, Stefanie Seltmann, Begona Aran, Rachel Steeg, Johannes Dewender, Nils Bultjer, Anna Veiga, Glyn N. Stacey, Andreas Kurtz

STEM CELL RESEARCH (2020)

Add to Collection

Article Cell & Tissue Engineering

The EBiSC iPSC bank for disease studies

Rachel Steeg, Julia C. Neubauer, Sabine C. Muller, Andreas Ebneth, Heiko Zimmermann

STEM CELL RESEARCH (2020)

Add to Collection

Article Cell & Tissue Engineering

Generation of two gene edited iPSC-lines carrying a DOX-inducible NGN2 expression cassette with and without GFP in the AAVS1 locus

Benjamin Schmid, Bjorn Holst, Ulla Poulsen, Ida Jorring, Christian Clausen, M. Rasmussen, Ulrike A. Mau-Holzmann, Rachel Steeg, Hugh Nuthall, A. Ebneth, A. Cabrera-Socorro

Summary: Neurog2 is a gene encoding the neuronal transcription factor NGN2, converting stem cells into functional neurons efficiently. Two iPS cell lines, BIONi010-C-13 and BIONi010-C-15, were generated with DOX-inducible constructs of neurog2, allowing differentiation into neurons when DOX is added.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

Development of a fully human assay combining NGN2-inducible neurons co-cultured with iPSC-derived astrocytes amenable for electrophysiological studies

Pei-Yu Shih, Mohamed Kreir, Devesh Kumar, Frederik Seibt, Francisco Pestana, Benjamin Schmid, Bjorn Holst, Christian Clausen, Rachel Steeg, Benjamin Fischer, Juan Pita-Almenar, Andreas Ebneth, Alfredo Cabrera-Socorro

Summary: Neurogenin 2 encodes NGN2, driving neuronal fate in cells; gene-edited hiPSC lines harbor NGN2 cassette; DOX-treated hiPSCs convert to neurons expressing structural markers.

STEM CELL RESEARCH (2021)

Add to Collection

Article Cell & Tissue Engineering

EBiSC best practice: How to ensure optimal generation, qualification, and distribution of iPSC lines

Rachel Steeg, Sabine C. Mueller, Nancy Mah, Bjorn Holst, Alfredo Cabrera-Socorro, Glyn N. Stacey, Paul A. De Sousa, Aidan Courtney, Heiko Zimmermann

Summary: The generation of disease-relevant human induced pluripotent stem cells requires adherence to ethical, legal, and quality standards, with best practices integrated into daily operations for maximizing their potential. Key experiences from operating the European Bank for induced Pluripotent Stem Cells (EBiSC) over 7 years are discussed, with recommendations on how to incorporate solutions into daily management framework.

STEM CELL REPORTS (2021)

Add to Collection

Article Reproductive Biology

Scalable expansion of iPSC and their derivatives across multiple lineages

Chee Keong Kwok, Isabelle Sebastien, Krithika Hariharan, Ina Meiser, Jeanette Wihan, Saskia Altmaier, Isabell Karnatz, Dominic Bauer, Benjamin Fischer, Alexander Feile, Alfredo Cabrera-Socorro, Mikkel Rasmussen, Bjorn Holst, Julia C. Neubauer, Christian Clausen, Catherine Verfaillie, Andreas Ebneth, Mattias Hansson, Rachel Steeg, Heiko Zimmermann

Summary: Induced pluripotent stem cells (iPSCs), with their ability to differentiate into various cell types, have become an important tool in biomedical research. This article discusses the development of scalable methods for large-scale production of iPSCs using 3D suspension culture platforms. It also highlights the establishment of robust differentiation protocols for cardiac, neural, and hepatic cell types to meet the increasing demand for research tools.

REPRODUCTIVE TOXICOLOGY (2022)

Add to Collection

Article Reproductive Biology

Human iPSC-derived hepatocytes in 2D and 3D suspension culture for cryopreservation and in vitro toxicity studies

Saskia Altmaier, Ina Meiser, Emilie Lemesre, Benjamin Chanrion, Rachel Steeg, Lidia Elena Leonte, Bjorn Holst, Boye Schnack Nielsen, Christian Clausen, Katharina Schmidt, Anne Marie Vinggaard, Heiko Zimmermann, Julia Christiane Neubauer, Mikkel Aabech Rasmussen

Summary: In this study, an optimized protocol for generating hepatocyte-like cells (HLCs) and hepatic organoids from hiPSCs was presented. The protocol was further translated to scalable suspension-based bioreactors to meet the increasing demand of hepatic cells. Cryopreservation approaches were also analyzed to ensure the maintenance of organoid phenotype.

REPRODUCTIVE TOXICOLOGY (2022)

Add to Collection

Article Cell & Tissue Engineering

SOX9-induced Generation of Functional Astrocytes Supporting Neuronal Maturation in an All-human System

Katrien Neyrinck, Johanna Van den Daele, Tim Vervliet, Jonathan De Smedt, Keimpe Wierda, Melissa Nijs, Tom Vanbokhoven, Astrid D'hondt, Melanie Planque, Sarah-Maria Fendt, Pei-Yu Shih, Frederik Seibt, Juan Pita Almenar, Mohamed Kreir, Devesh Kumar, Vania Broccoli, Geert Bultynck, Andreas Ebneth, Alfredo Cabrera-Socorro, Catherine Verfaillie

Summary: By overexpressing SOX9 in pluripotent stem cells, functionally mature human astrocytes can be generated, displaying comparable functional properties to primary human astrocytes. The electrophysiological properties of neurons co-cultured with these astrocytes are similar to murine primary cultures. This method allows for scaled-up production for high-throughput analysis, aiding in drug development and reducing animal use in biomedical research.

STEM CELL REVIEWS AND REPORTS (2021)

Add to Collection

No Data Available

© Peeref 2019-2024. All rights reserved.